Volume 25, Issue 3 (Iranian South Medical Journal 2022)                   Iran South Med J 2022, 25(3): 261-276 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bolkheir A R, Ostovar A, Moradinasab M, Larijani B. Nuclear Radiation and Thyroid Cancer; A Systematic Review. Iran South Med J 2022; 25 (3) :261-276
URL: http://ismj.bpums.ac.ir/article-1-1630-en.html
1- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran
The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
2- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran
3- The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
4- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran , larijanib1340@gmail.com
Abstract:   (343 Views)
Background: The increasing prevalence of thyroid cancer among the survivors of atomic bomb attacks in Japan, nuclear fallout in the Marshall Islands, and Chernobyl nuclear power plant accident indicate a strong relationship between nuclear radiation and the occurrence of thyroid cancer.
Materials and Methods: Systematic researches were conducted in the medical database of the American National Library of Congress, PubMed, using keywords of thyroid cancer, radiation, papillary thyroid cancer. After screening the titles and abstracts of 1791 citations, a total of 77 citations were identified to include in the current study.
Results: The latency period for developing nuclear radiation-induced thyroid cancers was 5 to 10 years to decades after exposure. The most important risk factor for developing radiation-induced thyroid cancer was the received radiation dose. A strong dose-response relationship between radiation dose and the incidence of thyroid cancer has been reported (P value<0.001). Also, a strong relationship between the age of exposure to nuclear radiation and the incidence of thyroid cancer has been reported among the survivors of atomic accidents. Although the incidence rate of thyroid cancer in girls was 2-3 times more than boys in some studies, in other studies from the Chernobyl accident, no gender effect was observed. The risk of radiation-induced thyroid cancer was estimated to be higher in areas with iodine deficiency. The most common route of internal radiation was through absorption of radioactive iodine isotopes via consumption of the contaminated milk. The main mechanism in the pathogenesis of radiation-induced thyroid cancer was activation of the MAPK pathway through genetic alterations (e.g., gene rearrangements in RET family and NTRK1) or point mutations (e.g., in BRAF). Among these genetic alteration, RET/PTC3 and RET/PTC1 rearrangements were more common in radiation--induced thyroid cancer. The clinical behavior of radiation-induced thyroid cancer was a non-invasive type similar to the sporadic one at the same age
Conclusion: Nuclear radiation, especially at a young age (under 20 years old), directly or indirectly in a dose-dependent manner via reactive oxygen species production induces gene alterations that underlie the increasing incidence of thyroid cancer after radiation exposure. Preparedness to deal with nuclear radiation including prescription of stable iodine prophylaxis, evacuation of the contaminated regions and restriction of access to contaminated foods are recommended in power plant accidents or atomic bomb explosions.
Full-Text [PDF 563 kb]   (74 Downloads)    
Type of Study: Review | Subject: Endocrine System
Received: 2022/05/28 | Accepted: 2022/07/13 | Published: 2022/09/22

References
1. Port M, Herodin F, Valente M, et al. MicroRNA expression for early prediction of late occurring hematologic acute radiation syndrome in baboons. PLoS ONE 2016; 11(11): e0165307. [DOI]
2. Kazzi Z, Buzzell J, Bertelli L, et al. Emergency department management of patients internally contaminated with radioactive material. Emerg Med Clin North Am 2015; 33(1): 179–196. [DOI]
3. Orton C, Borras C, Carlson D. Radiation biology for radiation therapy physicists. Med Phys 2014; 41(6): 532. [DOI]
4. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med 1991; 325(9): 599-605. [DOI]
5. Rubin P, Casarett GW. Clinical radiation pathology as applied to curative radiotherapy. Cancer 1968; 22(4): 767–780. [DOI]
6. Dilas LT, Bajkin I, Icin T, et al. Iodine and thyroid gland with or without nuclear catastrophe. Med Pregl 2012; 65(11-12): 489–495. [DOI]
7. Duffy BJ Jr, Fitzgerald PJ. Thyroid cancer in childhood and adolescence; a report on 28 cases. Cancer 1950; 3(6): 1018-32. [DOI]
8. Socolow EL, Hashizume A, Neriishi S, et al. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med 1963; 268: 406-10. [DOI]
9. Conard RA, Dobyns BM, Sutow WW. Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout. JAMA 1970; 214(2): 316-24. [PubMed]
10. Iglesias ML, Schmidt A, Ghuzlan AA, et al. Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab 2017; 61(2): 180-7. [DOI]
11. Schneider AB, Ron E, Lubin J, et al. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993; 77(2): 362-9. [DOI]
12. Naing S, Collins BJ, Schneider AB. Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence. Thyroid 2009; 19(5): 479-85. [DOI]
13. Furukawa K, Preston D, Funamoto S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer 2013; 132(5): 1222-6. [DOI]
14. Dobyns BM, Hyrmer BA. The surgical management of benign and malignant thyroid neoplasms in Marshall Islanders exposed to hydrogen bomb fallout. World J Surg 1992; 16(1): 126-39. [DOI]
15. Tronko MD, Howe GR, Bogdanova TI, et al. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst 2006; 98(13): 897-903. [DOI]
16. Zablotska LB, Bogdanova TI, Ron E, et al. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: dose-response analysis of thyroid follicular adenomas detected during first screening in Ukraine (1998-2000). Am J Epidemiol 2008; 167(3): 305-12. [DOI]
17. Shibata Y, Yamashita S, Masyakin VB, et al. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 2001; 358(9297): 1965-6. [DOI]
18. Ivanov VK, Gorski AI, Tsyb AF, et al. Radiation-epidemiological studies of thyroid cancerincidence among children and adolescents in the Bryansk oblast of Russia after the Chernobyl accident (1991-2001 follow-up period). Radiat Environ Biophys 2006; 45(1): 9-16. [DOI]
19. Ivanov VK, Kashcheev VV, Chekin SY, et al. Radiation-epidemiological studies of thyroid cancer incidence in Russia after the Chernobyl accident (estimation of radiation risks, 1991- 2008 follow-up period). Radiat Prot Dosimetry 2012; 151(3): 489-99. [DOI]
20. Ozasa K, Shimizu Y, Suyama A, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res 2012; 177(3): 229–243. [DOI]
21. Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005; 97(10): 724-32. [DOI]
22. Veiga LH, Holmberg E, Anderson H, et al. Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies. Radiat Res 2016; 185(5): 473-84. [DOI]
23. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005; 365(9476): 2014-23. [DOI]
24. Hall P, Holm LE. Radiation-associated thyroid cancer--facts and fiction. Acta Oncol 1998; 37(4): 325-30. [DOI]
25. Ohira T, Ohtsuru A, Midorikawa S, et al. External Radiation Dose, Obesity, and Risk of Childhood Thyroid Cancer After the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey. Epidemiology 2019; 30(6): 853-860. [DOI]
26. Reiners C, Demidchik YE, Drozd VM, et al. Thyroid cancer in infants and adolescents after Chernobyl. Minerva Endocrinol 2008; 33(4): 381-95. [PubMed]
27. Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012; 178(4): 365-76. [DOI]
28. Boice JD Jr. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA 2006; 295(9): 1060-2. [DOI]
29. Nabipour I, Assadi M. Use of Stable Iodine in Nuclear Emergencies. Bushehr: Bushehr university of medical science pub, 2010, 110. (Persian) [Article]
30. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995. Radiat Res 2012; 178(2): AV43-60. [DOI]
31. Matsuu-Matsuyama M, Shichijo K, Matsuda K, et al. Age-dependent effects on radiation-induced carcinogenesis in the rat thyroid. Sci Rep 2021; 11(1): 19096. [DOI]
32. Drozdovitch V. Radiation Exposure to the Thyroid After the Chernobyl Accident. Front Endocrinol (Lausanne) 2021; 11: 569041. [DOI]
33. de Vathaire F, Hardiman C, Shamsaldin A, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999; 159(22): 2713-9. [DOI]
34. Levin RJ, De Simone NF, Slotkin JF, et al. Incidence of thyroid cancer surrounding Three Mile Island nuclear facility: the 30-year followup. Laryngoscope 2013; 123(8): 2064-71. [DOI]
35. Bollaerts K, Fierens S, Van Bladel L, et al. Thyroid cancer incidence in the vicinity of nuclear sites in Belgium, 2000-2008. Thyroid 2014; 24(5): 906-17. [DOI]
36. Kim J, Bang Y, Lee WJ. Living near nuclear power plants and thyroid cancer risk: A systematic review and meta-analysis. Environ Int 2016; 87: 42-8. [DOI]
37. López-Abente G, Aragonés N, Pollán M. Solid-tumor mortality in the vicinity of uranium cycle facilities and nuclear power plants in Spain. Environ Health Perspect 2001; 109(7): 721-9. [DOI]
38. Kim BK, Kim JM, Kim MH, et al. Increased risk of thyroid cancer in female residents nearby nuclear power plants in Korea: was it due to detection bias? Ann Occup Environ Med 2018; 30: 21. [DOI]
39. de Vathaire F, Haddy N, Allodji RS, et al. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer. J Clin Endocrinol Metab 2015; 100(11): 4282-90. [DOI]
40. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation:a review of its current extent, risks, and implications. Endocr Rev 2010; 31(5): 756-73. [DOI]
41. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325(9): 599-605. [DOI]
42. Imaizumi M, Usa T, Tominaga T, et al. Radiation dose-response relationships forthyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 2006; 295(9): 1011-22. [DOI]
43. Tronko M, Bogdanova T, Voskoboynyk L, et al. Radiation induced thyroid cancer: fundamental and applied aspects. Exp Oncol 2010; 32(3): 200-4. [PubMed]
44. Islam MT. Radiation interactions with biological systems. Int J Radiat Biol 2017; 93(5): 487-493. [DOI]
45. Ermakova OV, Pavlov AV, Korableva TV. [Cytogenetic effects in follicular epithelium of thyroid gland under prolonged exposure to gamma-radiation at low-doses]. Radiats Biol Radioecol 2008; 48(2): 160-6. [PubMed]
46. Christov, K. Effect of irradiation on the proliferation kinetics of thyroid follicular cells in infant rats. Exp Pathol 1982; 21(2): 117–122. [DOI]
47. Russo E, Guerra A, Marotta V, et al. Radioiodide induces apoptosis in human thyroid tissue in culture. Endocrine 2013; 44(3): 729-34. [DOI]
48. Blasko I, Sztankay A, Lukas P, et al. Decreased thyroid peroxidase expression in cultured thyrocytes after external gamma irradiation. Exp Clin Endocrinol Diabetes 2000; 108(2): 138-41. [DOI]
49. Eheman CR, Garbe P, Tuttle RM. Autoimmune thyroid disease associated with environmental thyroidal irradiation. Thyroid 2003; 13(5): 453-64. [DOI]
50. Ameziane-El-Hassani R, Talbot M, de Souza Dos Santos MC, et al. NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc Natl Acad Sci U S A 2015; 112(16): 5051-6. [DOI]
51. Hara T, Namba H, Yang TT, et al. Ionizing radiation activates c-Jun NH2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells. Biochem Biophys Res Commun 1998; 244(1): 41-4. [DOI]
52. Caudill CM, Zhu Z, Ciampi R, et al. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J Clin Endocrinol Metab 2005; 90(4): 2364–2369. [DOI]
53. Albi E, Cataldi S, Lazzarini A, et al. Radiation and Thyroid Cancer. Int J Mol Sci 2017; 18(5): 911. [DOI]
54. Hamatani K, Eguchi H, Ito R, et al. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res 2008; 68(17): 7176-82. [DOI]
55. Suzuki K, Saenko V, Yamashita S, et al. Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures. Cancers (Basel) 2019; 11(9): 1290. [DOI]
56. Romei C, Elisei R. RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne) 2012; 3: 54. [DOI]
57. Zitzelsberger H, Unger K. DNA copy number alterations in radiation-induced thyroid cancer. Clin Oncol (R Coll Radiol) 2011; 23(4): 289-96. [DOI]
58. Oishi N, Kondo T, Nakazawa T, et al. Frequent BRAF V600E and absence of TERT promoter mutations characterize sporadic pediatric papillary thyroid carcinomas in Japan. Endocr Pathol 2017; 28(2): 103-111. [DOI]
59. Leeman-Neill RJ, Brenner AV, Little MP, et al. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer 2013; 119(10): 1792-9. [DOI]
60. Takahashi K, Eguchi H, Arihiro K, et al. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose. Mol Carcinog 2007; 46(3): 242–248. [DOI]
61. Ricarte-Filho JC, Li S, Garcia-Rendueles ME, et al. Identifification of kinase fusion oncogenes in Post-Chernobyl radiation-induced thyroidcancers. J Clin Invest 2013; 123(11): 4935–4944. [DOI]
62. Leeman-Neill RJ, Kelly LM, Liu P, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer 2014; 120(6): 799-807. [DOI]
63. Arndt A, Steinestel K, Rump A, et al. Anaplastic lymphoma kinase (ALK) gene rearrangements in radiation-related human papillary thyroid carcinoma after the Chernobyl accident. J Pathol Clin Res 2018; 4(3): 175-183. [DOI]
64. Efanov AA, Brenner AV, Bogdanova TI, et al. Investigation of the relationship between radiation dose and gene mutations and fusions in Post-Chernobyl thyroid cancer. J Natl Cancer Inst 2018; 110(4): 371-378. [DOI]
65. Hamatani K, Mukai M, Takahashi K, et al. Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors. Thyroid 2012; 22(11): 1153-9. [DOI]
66. Hamatani K, Eguchi H, Koyama K, et al. A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10) (p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation. Oncol Rep 2014; 32(5): 1809-14. [DOI]
67. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7(10): 569-80. [DOI]
68. Santoro M, Carlomagno F. Oncogenic rearrangements driving ionizing radiation-associated human cancer. J Clin Invest 2013; 123(11): 4566-8. [DOI]
69. Santoro M, Carlomagno F. Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol 2013; 5(12): a009233. [DOI]
70. Nikiforova MN, Tseng GC, Steward D, et al. MicroRNA expression profiling of thyroid tumors: Biological signifificance and diagnostic utility. J Clin Endocrinol Metab 2008; 93(5): 1600-8. [DOI]
71. He L, He X, Lim L, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130–1134. [DOI]
72. Nikiforova MN, Gandhi M, Kelly L, et al. MicroRNA dysregulation in human thyroid cells following exposure to ionizing radiation. Thyroid 2011; 21(3): 261-6. [DOI]
73. Sautin Y, Takamura N, Shklyaev S, et al. Ceramide-induced apoptosis of human thyroid cancer cells resistant to apoptosis by irradiation. Thyroid 2000; 10(9): 733-40. [DOI]
74. Fujiwara S, Sposto R, Shiraki M, et al. Levels of parathyroid hormone and calcitonin in serum among atomic bomb survivors. Radiat Res 1994; 137(1): 96-103. [PubMed]
75. Colaço SM, Si M, Reiff E, et al. Hyperparathyroidism after radioactive iodine therapy. Am J Surg 2007; 194(3): 323-7. [DOI]
76. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94(5): 524-32. [DOI]
77. International Atomic Energy Agency (IAEA). Intervention Criteria in a Nuclear or Radiation Emergency. IAEA Safety Series 1994; 109: 117. [Article]
78. Principles for Intervention for Protection of the Public in a Radiological Emergency. A report of a Task Group of Committee 4 of the International Commission on Radiological Protection. Ann ICRP 1991; 22(4): 1-39. [Article]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | ISMJ

Designed & Developed by: Yektaweb